Natural Alternatives International, Inc. (NAII) financial statements (2021 and earlier)

Company profile

Business Address 1535 FARADAY AVENUE
CARLSBAD, CA 92008-7319
State of Incorp. DE
Fiscal Year End June 30
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments27292528302824
Cash and cash equivalents27292528302824
Receivables15151717141416
Inventory, net of allowances, customer advances and progress billings23252627232524
Inventory23252627232524
Derivative instruments and hedges, assets2323   
Other undisclosed current assets2222432
Total current assets:69737176717065
Noncurrent Assets
Operating lease, right-of-use asset2020  
Property, plant and equipment21212121201919
Other noncurrent assets1111111
Total noncurrent assets:41422222222020
TOTAL ASSETS:1101159398939085
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11151418151514
Accounts payable510912101010
Accrued liabilities3234222
Employee-related liabilities1121221
Taxes payable2111111
Total current liabilities:11151418151514
Noncurrent Liabilities
Long-term debt and lease obligation2020     
Operating lease, liability2020  
Liabilities, other than long-term debt2222333
Accounts payable and accrued liabilities1112222
Deferred rent credit  1  11
Deferred tax liabilities, net111
Liability, pension and other postretirement and postemployment benefits000  00
Other liabilities   11  
Other undisclosed noncurrent liabilities1111   
Total noncurrent liabilities:222333333
Total liabilities:33381721181817
Stockholders' equity
Stockholders' equity attributable to parent76777677757268
Common stock0000000
Treasury stock, value(9)(8)(8)(8)(7)(7)(7)
Additional paid in capital27272626262524
Accumulated other comprehensive income (loss)(0)1011(0)(1)
Retained earnings59585758565351
Total stockholders' equity:76777677757268
TOTAL LIABILITIES AND EQUITY:1101159398939085

Income statement (P&L) ($ in millions)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
Revenues29293035363739
Cost of revenue
(Cost of Goods and Services Sold)
(24)(25)(27)(29)(30)(29)(33)
Gross profit:5446677
Operating expenses(4)(4)(4)(4)(4)(4)(4)
Operating income (loss):1(0)(1)2233
Nonoperating income (expense)(0)001101
Investment income, nonoperating0000110
Foreign currency transaction gain (loss), before tax(0)0(0)00(0)0
Income (loss) from continuing operations before income taxes:10(0)2334
Income tax expense (benefit)(0)(0)0(0)(1)(1)(1)
Net income (loss) available to common stockholders, diluted:00(0)2233

Comprehensive Income ($ in millions)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
Net income (loss):00(0)2233
Other undisclosed comprehensive income (loss)  (0)   0
Comprehensive income (loss):00(0)2233
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)0(1)0102
Comprehensive income (loss), net of tax, attributable to parent:(0)0(1)2335

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: